7. Effectiveness of day 4 frozen embryo transfer

Nguyen Thi Hanh, Nguyen Manh Ha

Main Article Content

Abstract

Currently, day 4 embryos are used for IVF transfer. However, it is not common and the effectiveness of the transfer is limited. This study aimed to initially evaluate the effectiveness of day 4 embryo transfer. This is a retrospective descriptive study of 149 cycles of day 4 frozen embryo transfer at the Center for IVF and Tissue Engineering, Hanoi Medical University Hospital from January 2022 to June 2023. The study evaluated the pregnancy outcome and affecting factors, including the quality of the transferred embryos, the number of transferred embryos, and the age of embryos at the freezing time. The mean age of patients was 30.21 ± 2.92 years old. The mean number of oocytes was 14.15 ± 7.04, mature oocytes mean was 10.88 ± 5.89. Fertilization rate was high at 85.43 ± 14.44 (%). Embryo quality was good, most were type 1 and type 2 embryos, accounting for over 90%. The results of our study showed that the pregnancy rate at day 4 embryo transfer was 57.7%. Transfer of at least 1 good embryo resulted in a statistically significant higher pregnancy rate compared to cycles without good embryos (63.4% and 16.67%, p < 0.0001). The number of transferred embryos and the age of embryos showed no statistically significant difference in pregnancy rate. However, further studies with larger sample sizes are needed to clarify the relationship between the number of embryos transferred and embryo age at freezing time with the outcome of day 4 embryo transfer. Our initial data suggested that day 4 embryo transfer could be applied widely for embryo transfer.

Article Details

References

1. Blake DA, Farquhar CM, Johnson N, Proctor M. Cleavage stage versus blastocyst stage embryo transfer in assisted conception. Cochrane Database Syst Rev. 2007 Oct 17.
2. Fong CY, Bongso A, Ng SC, Anandakumar C, Trounson A, Ratnam S. Ongoing normal pregnancy after transfer of zona-free blastocysts: implications for embryo transfer in the human. Hum Reprod. 1997 Mar.
3. Mark Perloe. Fewer risks, new hope: The reality of blastocyst transfer. copyright IVF. Com, Alanta, GA, USA. 2007.
4. Vassena R, Boué S, González-Roca E, Aran B, Auer H, Veiga A, Izpisua Belmonte JC. Waves of early transcriptional activation and pluripotency program initiation during human preimplantation development. Development. 2011 Sep.
5. Raul Artal- Mittelmark. Stages of Development of the Fetus. MSD MANUAL Consumer Version. 2022 Sep.
6. Kang SM, Lee SW, Jeong HJ, Yoon SH, Koh MW, Lim JH, Lee SG. Clinical outcomes of elective single morula embryo transfer versus elective single blastocyst embryo transfer in IVF-ET. J Assist Reprod Genet. 2012 May.
7. Li RS, Hwu YM, Lee RK, Li SH, Lin MH. Day 4 good morula embryo transfer provided compatible live birth rate with day 5 blastocyst embryo in fresh IVF/ET cycles. Taiwan J Obstet Gynecol. 2018 Feb.
8. Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Em- bryology, 2011. The Istanbul consensus workshop on embryo assessment: preceed- ings of an expert meeting. Hum. Reprod. 26, 1270-1283
9. Fernando J. Prados, Sophie Debrock, Josephine G. Lemmen, Inge Angerholm. The cleavage stage embryo, eds. Atlas of human embryology: from Oocytes to Preimplantation Embryos. Eshre. 2012.
10. Lee SH, Lee HS, Lim CK, Park YS, Yang KM, Park DW. Comparison of the clinical outcomes of day 4 and 5 embryo transfer cycles. Clin Exp Reprod Med. 2013 Sep.
11. Tao J, Tamis R, Fink K, Williams B, Nelson-White T, Craig R. The neglected morula/compact stage embryo transfer. Hum Reprod. 2001.
12. Jones GM, Trounson AO, Gardner DK, Kausche A, Lolatgis N, Wood C. Evolution of a culture protocol for successful blastocyst development and pregnancy. Hum Reprod. 1998.
13. Milki AA, Hinckley MD, Fisch JD, Dasig D, Behr B. Comparison of blastocyst transfer with day 3 embryo transfer in similar patient populations. Fertil Steril. 2000.